Peptide Therapeutics - Global Market Outlook (2019-2027)

   |      |      |  

Peptide Therapeutics - Global Market Outlook (2019-2027)

"The Global Peptide Therapeutics Market is accounted for $28.15 billion in 2019 and is expected to reach $66.76 billion by 2027 growing at a CAGR of 11.4% during the forecast period. Increasing prevalence of cancer, presence of strong product pipeline portfolio and an increasing number of cases of the metabolic disorder is driving the market growth. However, stringent government regulation for the approval process is hampering the growth of the market.

Peptides represent one of a kind class of pharmaceutical compounds; it is recognized for being adequate and specific. Demand for peptides in clinical therapeutics is increasing as peptides have low production complexity as compared with that of protein-based biopharmaceuticals, which thereby reduces overall production cost.

Based on the type, the innovative segment is going to have high growth during the forecast period owing to the increasing investments by huge pharmaceuticals in R&D for the development of novel medicines and high prescription rate. By geography, Asia Pacific is going to have high growth during the forecast period owing to the vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies.

Some of the key players profiled in the Peptide Therapeutics Market include Teva Pharmaceutical, Bachem Holding AG, Sanofi, Pfizer Inc., Amgen Inc., Novartis AG, Lonza Inc., GlaxoSmithKline (GSK), Eli Lilly and Company, Bristol-Myers Squibb(BMS), Merck & Co., AstraZeneca PLC, Novo Nordisk A/S, Ipsen, and Takeda Pharmaceutical Company Limited.

Types Covered:
• Innovative
• Generic
• Branded

Type of Manufacturers Covered:
• Outsourced
• In-house
• Contract Manufacturing Organizations (CMOs)

Route of Administrations Covered:
• Pulmonary
• Parenteral
• Oral
• Mucosal
• Injection
• Other Route of Administrations

Synthesis Technologies Covered:
• Solid Phase Peptide Synthesis (SPPS)
• Liquid Phase Peptide Synthesis (LPPS)
• Hybrid Technology

Type of Molecules Covered:
• Vasopressin
• Somatostatin
• Natriuretic
• Luteinizing Hormone (LH)-Releasing Hormone (LHRH)
• Insulins
• Immunopeptide
• Glucagon and Analogs
• Calcitonin

Applications Covered:
• Cancer
• Cardiovascular Disorder
• Metabolic
• Respiratory
• Gastro-Intestinal Infection (GIT)
• Pain
• Dermatology
• Anti-infection
• Central Nervous System
• Renal
• Infection
• Hematological Disorders
• Acromegaly
• Other Applications

End Users Covered:
• Pharmaceutical and Biotechnology Industries
• Hospitals
• Contract Research Organization
• Academic and Research Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Peptide Therapeutics Market, By Type
5.1 Introduction
5.2 Innovative
5.3 Generic
5.4 Branded

6 Global Peptide Therapeutics Market, By Type of Manufacturers
6.1 Introduction
6.2 Outsourced
6.3 In-house
6.4 Contract Manufacturing Organizations (CMOs)

7 Global Peptide Therapeutics Market, By Route of Administration
7.1 Introduction
7.2 Pulmonary
7.3 Parenteral
7.4 Oral
7.5 Mucosal
7.6 Injection
7.7 Other Route of Administrations
7.7.1 Nasal
7.7.2 Intradermal

8 Global Peptide Therapeutics Market, By Synthesis Technology
8.1 Introduction
8.2 Solid Phase Peptide Synthesis (SPPS)
8.3 Liquid Phase Peptide Synthesis (LPPS)
8.4 Hybrid Technology

9 Global Peptide Therapeutics Market, By Type of Molecule
9.1 Introduction
9.2 Vasopressin
9.3 Somatostatin
9.4 Natriuretic
9.5 Luteinizing Hormone (LH)-Releasing Hormone (LHRH)
9.6 Insulins
9.7 Immunopeptide
9.8 Glucagon and Analogs
9.9 Calcitonin

10 Global Peptide Therapeutics Market, By Application
10.1 Introduction
10.2 Cancer
10.2.1 Velcade (Bortezomib)
10.2.2 Zoladex (Goserelin)
10.2.3 Lupron\/ Enantone\/ Eligard (Leuprorelin)
10.3 Cardiovascular Disorder
10.3.1 Integrilin (Eptifibatide)
10.3.2 Angiomax (Bivalirudin)
10.4 Metabolic
10.4.1 Byetta (Exenatide)
10.4.2 Victoza (Liraglutide)
10.5 Respiratory
10.6 Gastro-Intestinal Infection (GIT)
10.6.1 Linzess (Linaclotide)
10.6.2 Gattex (Teduglutide)
10.7 Pain
10.8 Dermatology
10.9 Anti-infection
10.10 Central Nervous System
10.10.1 Copaxone (Glatiramer)
10.11 Renal
10.12 Infection
10.12.1 Victrelis (Boceprevir)
10.12.2 Incivek (Telaprevir)
10.13 Hematological Disorders
10.13.1 Kalbitor (Ecallantide)
10.13.2 Firazyr (Icatibant)
10.14 Acromegaly
10.15 Other Applications
10.15.1 Allergy\/Immunological
10.15.2 Osteoporosis

11 Global Peptide Therapeutics Market, By End User
11.1 Introduction
11.2 Pharmaceutical and Biotechnology Industries
11.3 Hospitals
11.4 Contract Research Organization
11.5 Academic and Research Institutes

12 Global Peptide Therapeutics Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa

13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies

14 Company Profiling
14.1 Teva Pharmaceutical
14.2 Bachem Holding AG
14.3 Sanofi
14.4 Pfizer Inc.
14.5 Amgen Inc.
14.6 Novartis AG
14.7 Lonza Inc.
14.8 GlaxoSmithKline (GSK)
14.9 Eli Lilly and Company
14.10 Bristol-Myers Squibb(BMS)
14.11 Merck & Co.
14.12 AstraZeneca PLC
14.13 Novo Nordisk A\/S
14.14 Ipsen
14.15 Takeda Pharmaceutical Company Limited

List of Tables
Table 1 Global Peptide Therapeutics Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Peptide Therapeutics Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Peptide Therapeutics Market Outlook, By Innovative (2018-2027) ($MN)
Table 4 Global Peptide Therapeutics Market Outlook, By Generic (2018-2027) ($MN)
Table 5 Global Peptide Therapeutics Market Outlook, By Branded (2018-2027) ($MN)
Table 6 Global Peptide Therapeutics Market Outlook, By Type of Manufacturers (2018-2027) ($MN)
Table 7 Global Peptide Therapeutics Market Outlook, By Outsourced (2018-2027) ($MN)
Table 8 Global Peptide Therapeutics Market Outlook, By In-house (2018-2027) ($MN)
Table 9 Global Peptide Therapeutics Market Outlook, By Contract Manufacturing Organizations (CMOs) (2018-2027) ($MN)
Table 10 Global Peptide Therapeutics Market Outlook, By Route of Administration (2018-2027) ($MN)
Table 11 Global Peptide Therapeutics Market Outlook, By Pulmonary (2018-2027) ($MN)
Table 12 Global Peptide Therapeutics Market Outlook, By Parenteral (2018-2027) ($MN)
Table 13 Global Peptide Therapeutics Market Outlook, By Oral (2018-2027) ($MN)
Table 14 Global Peptide Therapeutics Market Outlook, By Mucosal (2018-2027) ($MN)
Table 15 Global Peptide Therapeutics Market Outlook, By Injection (2018-2027) ($MN)
Table 16 Global Peptide Therapeutics Market Outlook, By Other Route of Administrations (2018-2027) ($MN)
Table 17 Global Peptide Therapeutics Market Outlook, By Nasal (2018-2027) ($MN)
Table 18 Global Peptide Therapeutics Market Outlook, By Intradermal (2018-2027) ($MN)
Table 19 Global Peptide Therapeutics Market Outlook, By Synthesis Technology (2018-2027) ($MN)
Table 20 Global Peptide Therapeutics Market Outlook, By Solid Phase Peptide Synthesis (SPPS) (2018-2027) ($MN)
Table 21 Global Peptide Therapeutics Market Outlook, By Liquid Phase Peptide Synthesis (LPPS) (2018-2027) ($MN)
Table 22 Global Peptide Therapeutics Market Outlook, By Hybrid Technology (2018-2027) ($MN)
Table 23 Global Peptide Therapeutics Market Outlook, By Type of Molecule (2018-2027) ($MN)
Table 24 Global Peptide Therapeutics Market Outlook, By Vasopressin (2018-2027) ($MN)
Table 25 Global Peptide Therapeutics Market Outlook, By Somatostatin (2018-2027) ($MN)
Table 26 Global Peptide Therapeutics Market Outlook, By Natriuretic (2018-2027) ($MN)
Table 27 Global Peptide Therapeutics Market Outlook, By Luteinizing Hormone (LH)-Releasing Hormone (LHRH) (2018-2027) ($MN)
Table 28 Global Peptide Therapeutics Market Outlook, By Insulins (2018-2027) ($MN)
Table 29 Global Peptide Therapeutics Market Outlook, By Immunopeptide (2018-2027) ($MN)
Table 30 Global Peptide Therapeutics Market Outlook, By Glucagon and Analogs (2018-2027) ($MN)
Table 31 Global Peptide Therapeutics Market Outlook, By Calcitonin (2018-2027) ($MN)
Table 32 Global Peptide Therapeutics Market Outlook, By Application (2018-2027) ($MN)
Table 33 Global Peptide Therapeutics Market Outlook, By Cancer (2018-2027) ($MN)
Table 34 Global Peptide Therapeutics Market Outlook, By Velcade (Bortezomib) (2018-2027) ($MN)
Table 35 Global Peptide Therapeutics Market Outlook, By Zoladex (Goserelin) (2018-2027) ($MN)
Table 36 Global Peptide Therapeutics Market Outlook, By Lupron\/ Enantone\/ Eligard (Leuprorelin) (2018-2027) ($MN)
Table 37 Global Peptide Therapeutics Market Outlook, By Cardiovascular Disorder (2018-2027) ($MN)
Table 38 Global Peptide Therapeutics Market Outlook, By Integrilin (Eptifibatide) (2018-2027) ($MN)
Table 39 Global Peptide Therapeutics Market Outlook, By Angiomax (Bivalirudin) (2018-2027) ($MN)
Table 40 Global Peptide Therapeutics Market Outlook, By Metabolic (2018-2027) ($MN)
Table 41 Global Peptide Therapeutics Market Outlook, By Byetta (Exenatide) (2018-2027) ($MN)
Table 42 Global Peptide Therapeutics Market Outlook, By Victoza (Liraglutide) (2018-2027) ($MN)
Table 43 Global Peptide Therapeutics Market Outlook, By Respiratory (2018-2027) ($MN)
Table 44 Global Peptide Therapeutics Market Outlook, By Gastro-Intestinal Infection (GIT) (2018-2027) ($MN)
Table 45 Global Peptide Therapeutics Market Outlook, By Linzess (Linaclotide) (2018-2027) ($MN)
Table 46 Global Peptide Therapeutics Market Outlook, By Gattex (Teduglutide) (2018-2027) ($MN)
Table 47 Global Peptide Therapeutics Market Outlook, By Pain (2018-2027) ($MN)
Table 48 Global Peptide Therapeutics Market Outlook, By Dermatology (2018-2027) ($MN)
Table 49 Global Peptide Therapeutics Market Outlook, By Anti-infection (2018-2027) ($MN)
Table 50 Global Peptide Therapeutics Market Outlook, By Central Nervous System (2018-2027) ($MN)
Table 51 Global Peptide Therapeutics Market Outlook, By Copaxone (Glatiramer) (2018-2027) ($MN)
Table 52 Global Peptide Therapeutics Market Outlook, By Renal (2018-2027) ($MN)
Table 53 Global Peptide Therapeutics Market Outlook, By Infection (2018-2027) ($MN)
Table 54 Global Peptide Therapeutics Market Outlook, By Victrelis (Boceprevir) (2018-2027) ($MN)
Table 55 Global Peptide Therapeutics Market Outlook, By Incivek (Telaprevir) (2018-2027) ($MN)
Table 56 Global Peptide Therapeutics Market Outlook, By Hematological Disorders (2018-2027) ($MN)
Table 57 Global Peptide Therapeutics Market Outlook, By Kalbitor (Ecallantide) (2018-2027) ($MN)
Table 58 Global Peptide Therapeutics Market Outlook, By Firazyr (Icatibant) (2018-2027) ($MN)
Table 59 Global Peptide Therapeutics Market Outlook, By Acromegaly (2018-2027) ($MN)
Table 60 Global Peptide Therapeutics Market Outlook, By Other Applications (2018-2027) ($MN)
Table 61 Global Peptide Therapeutics Market Outlook, By Allergy\/Immunological (2018-2027) ($MN)
Table 62 Global Peptide Therapeutics Market Outlook, By Osteoporosis (2018-2027) ($MN)
Table 63 Global Peptide Therapeutics Market Outlook, By End User (2018-2027) ($MN)
Table 64 Global Peptide Therapeutics Market Outlook, By Pharmaceutical and Biotechnology Industries (2018-2027) ($MN)
Table 65 Global Peptide Therapeutics Market Outlook, By Hospitals (2018-2027) ($MN)
Table 66 Global Peptide Therapeutics Market Outlook, By Contract Research Organization (2018-2027) ($MN)
Table 67 Global Peptide Therapeutics Market Outlook, By Academic and Research Institutes (2018-2027) ($MN)


Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
"

Peptide Therapeutics - Global Market Outlook (2019-2027)

.